Business Wire
BusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences for $2.88 billion, setting off investor focus on the deal’s strategic fitThe Apex TimesBusinessApple says it has evidence a former employee destroyed material after learning of an investigationThe Apex TimesBusinessTelecom comparison turns on profitability pace versus leverage: AT&T’s margin jump, Verizon’s debt loadThe Apex TimesBusinessAnthropic agrees to a $35 billion cloud computing deal tied to Nvidia-backed Lambda, report saysThe Apex TimesBusinessAMD has tended to fall in September, but market history is only part of the storyThe Apex TimesBusinessDuolingo shares jump after results point to steady user momentum, according to Yahoo FinanceThe Apex TimesBusinessNetflix confirms production of Korean series “Materesa (WT),” led by “Queen of Tears” director and writers behind “The East Palace”The Apex TimesBusinessFTC and 22 States Sue Amazon, Alleging It Secretly Marked Up Ads Shown to Marketplace SellersThe Apex TimesBusinessDeere shares gained as market focused on a jump in profitsThe Apex TimesBusinessBaird lifts Deere to Outperform, citing potential agricultural recovery and raises target to $800The Apex TimesBusinessVenezuela’s energy reopening talks could create upside for Chevron and GE Vernova, but agreements still face major hurdlesThe Apex TimesBusinessTrump Says ExxonMobil Is Preparing to Re-enter Venezuela as Investment Outlook ShiftsThe Apex Times
Back to front
Johnson & Johnson teams up with TIME to launch a new “Healthcare Champion of the Year” award
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jul 16, 8:40 AM EDT

Johnson & Johnson teams up with TIME to launch a new “Healthcare Champion of the Year” award

The healthcare company said it is collaborating with TIME on a new branded recognition meant to highlight healthcare professionals, though details on judging and rollout were not provided in the announcement.

Johnson & Johnson announced on July 16, 2026 that it is partnering with TIME to introduce a new branded recognition, “Healthcare Champion of the Year.” The award is designed to honor healthcare professionals, according to the announcement shared by Yahoo Finance.

The company did not outline, in the post describing the launch, what specific categories the award may cover, how many winners will be recognized, or what time frame the program will follow for submissions or nominations. Nor did it specify whether the recognition will include regional selections, an independent judging panel, or public voting.

While the announcement frames the award as a way to spotlight healthcare talent, it did not provide further information on how the recipients will be selected beyond the general goal of honoring healthcare professionals. It also did not disclose whether recipients will be recognized for clinical work, public health impact, research, health equity initiatives, patient advocacy, or other forms of contribution.

The collaboration is branded, meaning TIME’s media platform will be part of the program’s visibility. Johnson & Johnson did not say how TIME and the company will divide responsibilities for editorial content, judging governance, or event production tied to the award.

In the broader context, branded awards are a common form of corporate engagement in healthcare and other industries, often used to amplify professional excellence and to build visibility around health-related themes. For large healthcare companies like Johnson & Johnson, such initiatives can also serve as a platform for communications that reach clinicians, administrators, and public audiences.

Because the announcement did not include program specifics, investors and observers may be watching for follow-up disclosures on the mechanics of the award. That includes details about entry requirements, the geographic scope, and whether there are planned dates for announcing finalists and selecting a winner.

As of the announcement date, Johnson & Johnson and TIME did not provide numbers or financial information tied to the program, such as expected marketing costs, estimated budget ranges, or any view into how the award might support broader commercial or brand objectives.

The next item to watch is whether TIME or Johnson & Johnson publishes nomination guidance and selection criteria, along with dates for the first “Healthcare Champion of the Year” recognition. Observers may also look for disclosures on partners involved in judging or advisory roles, if any, given the award’s professional focus.

Why It Matters

  • Corporate-media collaborations can shape public attention on healthcare priorities and may influence how audiences perceive companies’ commitments to the sector.
  • If the award expands to an ongoing annual program, it could become a recurring platform for healthcare communications and professional recognition.
  • The lack of disclosed selection mechanics may limit near-term clarity on credibility and transparency until further details are published.
  • Follow-on guidance on nominations, criteria, and judging governance could be important for clinicians and healthcare organizations considering participation or endorsement.

Sources

Key Facts

  • Johnson & Johnson announced a collaboration with TIME to launch the “Healthcare Champion of the Year” award.
  • The award is intended to honor healthcare professionals.
  • The announcement was published on July 16, 2026.
  • In the posted announcement, Johnson & Johnson did not provide details on nomination or selection criteria, judging structure, or program timing.
  • The announcement did not include any budget, financial, or performance metrics tied to the program.

Healthcare Related

Johnson & Johnson teams up with TIME to launch a new “Healthcare Champion of the Year” award | The Apex Times